Our websites use cookies to offer you a better browsing experience and analyze site traffic. By using our websites, you consent to our use of cookies.
The continuous manufacturing in the pharmaceutical industry for drug substance synthesis and drug product processing is shifting the manufacturing paradigm. The significant impacts have been demonstrated for process intensification, improving quality consistency, shorten drug-to-market time, business competitive advantage, adopting advanced manufacturing, and improving profit margin.
The audience will learn the advantages and challenges of continuous manufacturing compared to batch processing. The webinar will cover four sections of the bio/pharma industry for continuous manufacturing of: (1) Drug substance; (2) Drug product; (3) Biologics upstream; and (4) Biologics downstream. Case studies and examples will be discussed to explore fundamental technical and business considerations, workflow, technoeconomical analysis, scale-up/down issues, and regulatory considerations.
What you’ll learn:
This webinar is part of ongoing Education & Workforce Development efforts of the RAPID Manufacturing Institute. Webinars are free to RAPID Members.
Webinar content is available with the kind permission of the author(s) solely for the purpose of furthering AIChE’s mission to educate, inform and improve the practice of professional chemical engineering. The content reflects the views, opinions, and recommendations of the presenters. AIChE does not warrant or represent, expressly or by implication, the correctness or accuracy of the content of the information presented. All other uses are forbidden without the express consent of the author(s). For permission to re-use, please contact chemepermissions@aiche.org. Attendee contact information, including email addresses, will be shared with AIChE, with the option to unsubscribe from future communications.